Meanwhile in Italy, a group of researchers....this study discusses the development of immunoliposome-based CRISPR/Cas9 delivery targeting IL30 in prostate cancer. In vivo and in vitro it showed great results in inhibiting tumor growth and metastasis formation. Alteration of tumor environment (reduced evasion ability) and low toxicity are a plus! Hopefully we will have someone willing to invest in this discovery soon!
In vivo/vitro latest immunotherapy pr... - Advanced Prostate...
In vivo/vitro latest immunotherapy proof of concept by targeting IL30 in prostate cancer
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
7 Replies
•
Meanwhile in Italy, a group (I think you meant a clan)....
Good Luck, Good Health and Good Humor.
j-o-h-n
come on! you know we don't say that out loud! 🤦♂️
You gotta nero hand it to me........dumb is as stupid is.........and me driving that new "Mafia" I.T. sports car that comes equipped with 2 hoods......
Good Luck, Good Health and Good Humor.
j-o-h-n
Not what you're looking for?
You may also like...
Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
New study.
I'd like to point out that a mouse study should not be rejected out of hand because it...
Nano-targeting treatment for prostate cancer
https://www.eurekalert.org/pub_releases/2017-11/aaop-ntf111017.php
Public Release: 13-Nov-2017...
Microbiome signatures in prostate cancer.
New study [1]. I don't believe this subject has come up before.
There was a recent thread where...
Estrogen receptor signaling in prostate cancer.
New paper below [1].
At least by 10 years ago there were papers warning that androgens & the...
Progesterone Receptors in Prostate Cancer.
New study below [1].
The trouble with Charles Huggins castration therapy of 1941, which looks as...